Contrast Agents Market 2021 | Explosive Factors of Revenue by Manufacturing Size, Share, Opportunities, Industry Expansion Strategies and Global Analysis by Forecast to 2030

In a recent published report, Kenneth Research has updated the market report for Contrast Agents Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Contrast Agents Market products.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10169101

Moreover, the median health expenditure per capita recorded in the high-income, upper-middle income, and low & lower-middle income countries, recorded to be over USD 2,000, USD 400, and USD 100 respectively. Additionally, in the same year, the spending on health in high-income countries and in the low- and middle-income countries comprised approximately 8.2% and 6.3% of the GDP respectively.

Global Contrast Agents Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025
[70 pages report] This market research report includes a detailed segmentation of the global contrast agents market by product type (Iodinated, Barium-based, Gadolinium-based, Microbubble-based, and Others), by modality type (X-Ray/Computed Tomography, Magnetic Resonance Imaging, and Ultrasound), by region (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global Contrast Agents Market
Kenneth’s market research report predicts that the “Global Contrast Agents Market” will grow at a CAGR of ~4.0% during the forecast period 2019–2025. The market has witnessed steady growth in the past few years and is sustaining due to rising demand for diagnostic and interventional radiology procedures and increase in incidence and prevalence of disease conditions are drivers of the market.

Expansion in indications of contrast media market and the growth of medical imaging technologies in emerging markets are providing opportunities for the growth of the contrast agents market. However, side effects associated with contrast agents and stringent regulations for contrast agents are factors hampering the market growth.
The majority of the revenue is generated from the leading players in the market with dominating sales from Taejoon Pharm Co., Ltd., GE Healthcare, Bayer, Fujifilm Holdings Corporation, Bracco Group, and Beijing Beilu Pharmaceutical Co., Ltd.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10169101

According to the analysis, North America accounted for the largest share of the global contrast agents market in 2018. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.

By Product Type:
*Iodine-based
*Barium-based
*Gadolinium-based
*Microbubble-based
*Others

Iodinated contrast agent is the major shareholder in the contrast agents market in 2018.
By Modality:
*X-ray/CT
*MRI
*Ultrasound

X-ray holds major share in the contrast agents market in 2018. Due to the growing investment and developments in the ultrasound contrast agent industry, the demand for ultrasound contrast agents is expected to grow at a rapid rate during the forecast period.

By Regions:
*North America
*Europe
*APAC
*RoW

North America was dominant in the global contrast agents market in 2018. The significant share of the North American region comes from the US, owing to the accessibility to good quality healthcare and good reimbursement facilities.

Contrast Agents Market Research Competitive Analysis – GE, Guerbet, and Bayer have been the major players in the market due to their top selling products and has secured major share in the market. Bayer has Gadavist/Gadovist, the major MRI contrast agent, a macrocyclic gadolinium agent to its benefit. Guerbet claims to own second position in the MRI contrast agents market, fourth position in CT & Cath lab imaging contrast media and third position in the contrast media injection medical devices and services globally. A portion of its range of offers, GE competes with Omnipaque and Visipaque. The three players own nearly half of the market share.

Key Vendors
*Taejoon Pharm Co., Ltd
*GE Healthcare
*Bayer AG
*Fujifilm Holdings Corporation
*Bracco Group
*Beijing Beilu Pharmaceutical Co., Ltd

Key Competitive Facts
*Strict government regulations and high cost of products hinders the entry of new players and many players have commandable share in the market.
*Adverse reimbursement scenario and high cost of imaging modalities in emerging countries may hamper the market growth.

Benefits – The report provides complete details about the sub-segments of the contrast agents market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the disease management in the upcoming years along with details of the existing pure-play companies and new players entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10169101

Key Takeaways:
*Understanding the potential market opportunity with precise market size and forecast data.
*A detailed market analysis focusing on the growth of the contrast agents industry.
*Factors influencing the growth of the contrast agents market.
*In-depth competitive analysis of dominant and pure-play vendors.
*Prediction analysis of the contrast agents market in both developed and developing regions.
*Key insights related to major segments of the contrast agents market.
*Latest market trend analysis impacting the buying behavior of the consumers.

Table of Contents
1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market (SAM)
3.3 Industry Trends
3.4 Related Markets
3.4.1 Medical Imaging
4 Market Outlook
4.1 Market Segmentation
4.2 Porter 5 (Five) Forces
5 Market Characteristics
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Rising demand for diagnostic and interventional radiology procedures
5.1.1.2 Increase in incidence and prevalence of disease conditions
5.1.2 Restraints
5.1.2.1 Side effect associated with contrast agents
5.1.2.2 Stringent regulations for contrast agents
5.1.3 Opportunities
5.1.3.1 Expansion in indications of contrast media market
5.1.3.2 The growth of medical imaging technologies in emerging markets
5.1.4 DRO – Impact Analysis
5.2 Key Stakeholders
6 Products: Market Size and Analysis
6.1 Iodine Based Contrast Agent
6.2 Barium Based Contrast Agent
6.3 Gadolinium Based Contrast Agent
6.4 Microbubble Based Contrast Agent
6.5 Other Contrast Agent
7 Modality: Market Size and Analysis
7.1 Overview
7.2 X-Ray and Computerized Tomography (CT)
7.3 Magnetic Resonance Imaging (MRI)
7.4 Ultrasound
8 Regions: Market Size and Analysis
8.1 Overview
8.2 North America
8.2.1 Overview
8.3 Europe
8.3.1 Overview
8.4 Asia Pacific
8.4.1 Overview
8.5 Rest of the World

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1-(347)-627-0064

James Bullock is a Research Expert with a demonstrated history of working in the professional training & coaching industry. Strong professional skilled in business strategy , Strategic Planning, Research Strategy, and Marketing. also have interest in new innovations and technology

Leave a Reply